Azimine hydrochloride tablet and preparation method thereof
By optimizing the composition and preparation process of Asimini Hydrochloride tablets, combining film coating and variable speed cutting and stirring wet granulation, the dissolution and uniformity of Asimini Hydrochloride tablets are solved, and the quality performance of the product is significantly improved.
Patent Information
- Application Number
- CN202410945927.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-15
- Publication Date
- 2024-11-05
AI Technical Summary
The existing ascimini hydrochloride tablets have poor dissolution and poor uniformity of the central control dosage unit, resulting in prescription quality problems.
Ascimini hydrochloride tablets are made of ascimini hydrochloride sheet core and film coating. The specific ingredients include ascimini hydrochloride, diluent, binder, disintegrant, glidant and lubricant, film The coating consists of polyvinyl alcohol, titanium dioxide, talc, lecithin, xanthan gum and colorant, and is optimized by variable speed cutting and stirring wet granulation and fluidized bed drying process.
The dissolution of ascimini hydrochloride tablets and the uniformity of the centrally controlled dose units are improved, and the quality performance indicators are improved, including properties, particle size distribution, moisture, content uniformity and stability.
Smart Images

Figure BDA0004945621650000051 
Figure BDA0004945621650000061 
Figure BDA0004945621650000062
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medicines, and in particular relates to an asciminid hydrochloride tablet and a preparation method thereof. Background Art
[0002] The Chinese chemical name of Asciminib is N-[4-(chlorodifluoromethoxy)phenyl-6-(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide. The stabilizing component of the preparation is a 1:1 hydrochloride salt, namely Asciminib hydrochloride, with the generic name Asciminib hydrochloride. Asciminib is a STAMP inhibitor that can overcome mutations in the ATP binding site of BCR-ABL1, help solve TKI resistance in the late stage of CML treatment, solve off-target activity, and improve patient prognosis. The main indication is chronic myeloid leukemia that is resistant or intolerant to previous treatment drugs. The existing Asciminib hydrochloride tablets are mainly in the form of film coating, but the product dissolution is poor, the central control measurement unit is poorly uniform, and there are a series of prescription quality problems. Summary of the invention
[0003] The object of the present invention is to provide an asciminid hydrochloride tablet and a preparation method thereof, so as to solve the problems of poor dissolution and poor uniformity of the central controlled dosage unit of the existing asciminid hydrochloride tablets in the background technology.
[0004] The purpose of the present invention can be achieved through the following technical solutions:
[0005] An asciminid hydrochloride tablet is composed of an asciminid hydrochloride tablet core and a film coating, wherein the asciminid hydrochloride tablet core comprises the following components in parts by weight:
[0006] Assimil hydrochloride 20-45 parts, diluent A 40-90 parts, diluent B 20-60 parts, binder 2-10 parts, disintegrant 2-8 parts, glidant 0.2-1.2 parts, lubricant 0.5-2.5 parts;
[0007] The film coating comprises the following components in percentage: 70wt% polyvinyl alcohol, 3wt% titanium dioxide, 2wt% talcum powder, 10wt% lecithin, 10wt% xanthan gum, and 5wt% colorant;
[0008] The film coating increases the weight of the asciminid hydrochloride tablet core by 2-3.5%.
[0009] As a further embodiment of the present invention, the diluent A is lactose monohydrate, the diluent B is microcrystalline cellulose, the binder is hydroxypropyl cellulose, the disintegrant is cross-linked sodium carboxymethyl cellulose, the glidant is colloidal silicon dioxide, and the lubricant is magnesium stearate.
[0010] As a further embodiment of the present invention, the colorant is composed of red iron oxide and yellow iron oxide in a mass ratio of 2:3 or red iron oxide and black iron oxide in a mass ratio of 2:3.
[0011] As a further embodiment of the present invention, the asciminid hydrochloride tablet core comprises the following components in parts by weight: 21-22 parts of asciminid hydrochloride, 42-44 parts of lactose monohydrate, 28-29 parts of microcrystalline cellulose, 3.5-4.5 parts of hydroxypropyl cellulose, 2.5-3.5 parts of cross-linked sodium carboxymethyl cellulose, 0.3-0.7 parts of colloidal silicon dioxide, and 0.5-1.5 parts of magnesium stearate.
[0012] As a further embodiment of the present invention, the asciminid hydrochloride tablet core comprises the following components in parts by weight: 21.62 parts of asciminid hydrochloride, 43 parts of lactose monohydrate, 28.88 parts of microcrystalline cellulose, 4 parts of hydroxypropyl cellulose, 3 parts of cross-linked sodium carboxymethyl cellulose, 0.5 parts of colloidal silicon dioxide, and 1 part of magnesium stearate.
[0013] As a further embodiment of the present invention, the asciminid hydrochloride tablet core comprises the following components in parts by weight: 43-44 parts of asciminid hydrochloride, 85-87 parts of lactose monohydrate, 57-58 parts of microcrystalline cellulose, 7.5-8.5 parts of hydroxypropyl cellulose, 5.5-6.5 parts of cross-linked sodium carboxymethyl cellulose, 0.5-1.5 parts of colloidal silicon dioxide, and 1.5-2.5 parts of magnesium stearate.
[0014] Preferably, the asciminid hydrochloride tablet core comprises the following components in parts by weight: 43.24 parts of asciminid hydrochloride, 86 parts of lactose monohydrate, 57.76 parts of microcrystalline cellulose, 8 parts of hydroxypropyl cellulose, 6 parts of cross-linked sodium carboxymethyl cellulose, 1 part of colloidal silicon dioxide, and 2 parts of magnesium stearate.
[0015] A method for preparing asinethimide hydrochloride tablets comprises the following steps:
[0016] S1. Preparation of Asinimipine Hydrochloride Tablet Cores:
[0017] 1) Weighing the tablet core components by weight, preparing a binder solution with a mass concentration of 8-12 wt% with purified water; adding diluent A, disintegrant, diluent B and binder solution to assimil hydrochloride to obtain a mixed material, and wet granulating with variable speed cutting and stirring, and then wet granulating;
[0018] 2) drying the prepared wet granules, adding a glidant, adding a lubricant after dry granulation, mixing, and tableting to obtain ascinimidazole hydrochloride tablet cores;
[0019] S2. Preparation of Asinimid Hydrochloride Tablets:
[0020] Weigh each component of the film coating according to the percentage content, then add each component of the film coating into water to prepare a solution with a mass concentration of 8-12wt%, and coat the core of the acinemide hydrochloride tablet to obtain the acinemide hydrochloride tablet.
[0021] As a further solution of the present invention, the variable speed cutting and stirring wet granulation comprises the following steps:
[0022] A. High-speed stirring and low-speed cutting: The mixed materials are pre-mixed at a stirring speed of 6-8rpm and a cutting rate of 0rpm for 4-6min;
[0023] B. High-speed cutting and low-speed stirring: adjust the stirring rate to 2-3 rpm and the cutting rate to 20-30 rpm for mixing, and atomize at a pressure of 0.05-0.2 MPa for 6-10 minutes. Determine whether wet granulation is performed by the state of the particles.
[0024] As a further solution of the present invention, the specification of the wet granulation screen is 4×4 mm; the specification of the dry granulation screen is 1.2×1.2 mm.
[0025] As a further solution of the present invention, fluidized bed drying is adopted to dry the mixture to a solid content of 1-3%.
[0026] As a further solution of the present invention, the mixing time of adding the lubricant after the dry granulation is 8-15 minutes.
[0027] Beneficial effects of the present invention:
[0028] 1. The present invention provides an asinemid hydrochloride tablet. By optimizing the ratio of ingredients, the prepared asinemid hydrochloride tablet has good dissolution, good uniformity of the central controlled dosage unit, and good content uniformity and other indicators; in addition, by optimizing the addition form of hydroxypropyl cellulose, the quality performance indicators of the asinemid hydrochloride tablet can be effectively improved. In the present invention, the properties, particle size distribution, moisture, related substances, content, content uniformity, dissolution curve, and stability of the asinemid hydrochloride tablet all meet the requirements, the weight parts and the preparation process complement each other, the operability is strong, and the product quality is controllable.
[0029] 2. The present invention provides a method for preparing assinimidol hydrochloride tablets, which comprises the following steps: firstly stirring at a high speed and cutting at a low speed (0 rpm) to allow friction and collision between particles of the mixed material, and cutting at a rate of 0 rpm to avoid precipitation of a large number of crystals during the early material mixing process; then stirring at a low speed and cutting at a high speed to allow the mixed material to reach a certain mixing state, and the high-speed cutting rate is used to allow cross-linking and mixing between the components, and is more conducive to interaction with subsequent flow aids and lubricants, thereby achieving improved solubility and uniformity of the drug. DETAILED DESCRIPTION
[0030] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0031] An asciminid hydrochloride tablet is composed of an asciminid hydrochloride tablet core and a film coating, wherein the asciminid hydrochloride tablet core comprises the following components in parts by weight:
[0032] Assimil hydrochloride 20-45 parts, lactose monohydrate 40-90 parts, microcrystalline cellulose 20-60 parts, hydroxypropyl cellulose 2-10 parts, cross-linked carboxymethyl cellulose sodium 2-8 parts, colloidal silicon dioxide 0.2-1.2 parts, magnesium stearate 0.5-2.5 parts;
[0033] The film coating comprises the following components in percentage: 70wt% of polyvinyl alcohol, 3wt% of titanium dioxide, 2wt% of talc, 10wt% of lecithin, 10wt% of xanthan gum, and 5wt% of colorant.
[0034] A method for preparing asinethimide hydrochloride tablets comprises the following steps:
[0035] S1. Preparation of Asinimipine Hydrochloride Tablet Cores:
[0036] 1) Weighing each component of the tablet core by weight, preparing a hydroxypropyl cellulose solution with a mass concentration of 8-12wt% by using purified water; adding lactose monohydrate, cross-linked sodium carboxymethyl cellulose, microcrystalline cellulose and hydroxypropyl cellulose solution to axine hydrochloride to obtain a mixed material, and performing high-speed stirring and low-speed cutting premixing at a stirring speed of 6-8rpm and a cutting rate of 0rpm for 4-6min; then adjusting the stirring rate to 2-3rpm, and the cutting rate to 20-30rpm for high-speed cutting and low-speed stirring and mixing, and simultaneously atomizing at a pressure of 0.05-0.2MPa for 6-10min, and after wet granulation by variable speed cutting and stirring, wet granulation is performed with a 4×4mm sieve;
[0037] 2) drying the prepared wet granules in a fluidized bed until the solid content is 1-3%, adding colloidal silicon dioxide, adding magnesium stearate after drying the granules through a 1.2×1.2 mm sieve, mixing for 8-15 minutes, and tableting to obtain acinilamide hydrochloride tablet cores;
[0038] S2. Preparation of Asinimid Hydrochloride Tablets:
[0039] Weigh each component of the film coating according to the percentage content, then add each component of the film coating into water to prepare a solution with a mass concentration of 10wt%, and coat the core of the acinemide hydrochloride tablet to obtain the acinemide hydrochloride tablet.
[0040] Example 1
[0041] A kind of acinamide hydrochloride tablets, the unit preparation prescription is shown in Table 1:
[0042] Table 1
[0043]
[0044]
[0045] The preparation method of the asinimipine hydrochloride tablets comprises the following steps:
[0046] S1. Preparation of Asinimipine Hydrochloride Tablet Cores:
[0047] 1) Weighing each component of the tablet core according to the unit dosage, preparing a hydroxypropyl cellulose solution with a mass concentration of 10 wt% by using purified water; adding lactose monohydrate, cross-linked sodium carboxymethyl cellulose, microcrystalline cellulose and hydroxypropyl cellulose solution to axinemidazole hydrochloride to obtain a mixed material, and performing high-speed stirring and low-speed cutting premixing at a stirring speed of 8 rpm and a cutting rate of 0 rpm for 5 minutes; then adjusting the stirring rate to 2 rpm and the cutting rate to 25 rpm for high-speed cutting and low-speed stirring and mixing, and atomizing at a pressure of 0.1 MPa for 8 minutes, and after wet granulation by variable speed cutting and stirring, wet granulation is performed with a 4×4 mm sieve;
[0048] 2) drying the prepared wet granules in a fluidized bed until the solid content is 2%, adding colloidal silicon dioxide, adding magnesium stearate after granulation through a 1.2×1.2 mm sieve, mixing for 10 minutes, and punching into tablets using a No. 6 punch to obtain a 0.102 g acinamide hydrochloride tablet core;
[0049] S2. Preparation of Asinimid Hydrochloride Tablets:
[0050] Weigh each component of the film coating according to the percentage content, then add each component of the film coating into water to prepare a solution with a mass concentration of 10wt%, and coat the core of the acinemide hydrochloride tablet to obtain the acinemide hydrochloride tablet.
[0051] Example 2
[0052] A kind of acinamide hydrochloride tablets, the unit preparation prescription is shown in Table 2:
[0053] Table 2
[0054]
[0055]
[0056] The preparation method of the asinimipine hydrochloride tablets is the same as that of Example 1, except that a No. 8 punching sheet is used to obtain an asinimipine hydrochloride tablet core with a mass of 0.204 g, and the other steps and parameters remain the same.
[0057] Example 3
[0058] A kind of acinamide hydrochloride tablets, the unit preparation prescription is shown in Table 3:
[0059] Table 3
[0060]
[0061]
[0062] The preparation method of the asinimipine hydrochloride tablets is the same as that of Example 1, except that a No. 8 punching sheet is used to obtain an asinimipine hydrochloride tablet core with a mass of 0.203 g, and the other steps and parameters remain the same.
[0063] Comparative Example 1
[0064] A kind of acinamide hydrochloride tablets, the unit preparation formula is the same as that of Example 1, as shown in Table 1;
[0065] The preparation method of the asinimipine hydrochloride tablets is the same as that of Example 1, except that hydroxypropyl cellulose is prepared into a hydroxypropyl cellulose solution with a mass concentration of 20 wt % using purified water, and the other steps and parameters remain the same.
[0066] Comparative Example 2
[0067] A kind of acinamide hydrochloride tablets, the unit preparation formula is the same as that of Example 1, as shown in Table 1;
[0068] The preparation method of the asinimines hydrochloride tablets is the same as that of Example 1, except that lactose monohydrate, cross-linked sodium carboxymethyl cellulose, microcrystalline cellulose and hydroxypropyl cellulose are added to asinimines hydrochloride, and then the same amount of purified water as in the preparation method of Example 1 is added, and the mixture is uniformly mixed to obtain a mixed material, and the remaining steps and parameters remain the same.
[0069] Comparative Example 3
[0070] A kind of acinamide hydrochloride tablets, the unit preparation formula is the same as that of Example 1, as shown in Table 1;
[0071] The preparation method of the asinimipine hydrochloride tablets is the same as that of Example 1, except that hydroxypropyl cellulose is prepared into a hydroxypropyl cellulose solution with a mass concentration of 1 wt % using purified water, and the other steps and parameters remain the same.
[0072] Comparative Example 4
[0073] A kind of acinamide hydrochloride tablets, the unit preparation formula is the same as that of Example 1, as shown in Table 1;
[0074] The preparation method of the asinethimide hydrochloride tablets, in step 1), the order of the variable speed cutting and stirring wet granulation is changed, and specifically comprises the following steps:
[0075] S1. Preparation of Asinimipine Hydrochloride Tablet Cores:
[0076] 1) Weighing each component of the tablet core according to the unit dosage, preparing a hydroxypropyl cellulose solution with a mass concentration of 10 wt% by using purified water; adding lactose monohydrate, cross-linked sodium carboxymethyl cellulose, microcrystalline cellulose and hydroxypropyl cellulose solution to axinemidazole hydrochloride to obtain a mixed material, performing high-speed cutting and low-speed stirring premixing at a stirring rate of 2 rpm and a cutting rate of 25 rpm for 5 minutes, and then performing high-speed stirring and low-speed cutting mixing at a stirring speed of 8 rpm and a cutting rate of 0 rpm, and atomizing at a pressure of 0.1 MPa for 8 minutes, and after wet granulation by variable speed cutting and stirring, wet granulation is performed with a 4×4 mm sieve;
[0077] 2) Same as Example 1;
[0078] S2 is the same as Example 1.
[0079] Comparative Example 5
[0080] A kind of acinamide hydrochloride tablets, the unit preparation formula is the same as that of Example 1, as shown in Table 1;
[0081] The preparation method of the asinethimide hydrochloride tablets, in step 1), adopts uniform cutting and stirring wet granulation, specifically comprising the following steps:
[0082] S1. Preparation of Asinimipine Hydrochloride Tablet Cores:
[0083] 1) Weighing each component of the tablet core according to the unit dosage, preparing a hydroxypropyl cellulose solution with a mass concentration of 10 wt% by using purified water; adding lactose monohydrate, cross-linked sodium carboxymethyl cellulose, microcrystalline cellulose and hydroxypropyl cellulose solution to acinil hydrochloride to obtain a mixed material, stirring and mixing at a stirring rate of 5 rpm and a cutting rate of 15 rpm, and atomizing at a pressure of 0.1 MPa for 13 min, and wet granulating with uniform cutting and stirring, and then wet granulating with a 4×4 mm sieve;
[0084] 2) Same as Example 1;
[0085] S2 is the same as Example 1.
[0086] Comparative Example 6
[0087] A kind of acinamide hydrochloride tablets, the unit preparation formula is the same as that of Example 1, as shown in Table 1;
[0088] The preparation method of the asinimipine hydrochloride tablets, in step 1), does not involve cutting or stirring, and specifically comprises the following steps:
[0089] S1. Preparation of Asinimipine Hydrochloride Tablet Cores:
[0090] 1) Weighing each component of the tablet core according to the unit dosage, preparing a hydroxypropyl cellulose solution with a mass concentration of 10 wt% by using purified water; adding lactose monohydrate, cross-linked sodium carboxymethyl cellulose, microcrystalline cellulose and hydroxypropyl cellulose solution to axinemidil hydrochloride to obtain a mixed material, and pre-mixing the mixture at a stirring speed of 8 rpm for 5 minutes; then adjusting the stirring speed to 2 rpm, stirring and mixing at a low speed, and atomizing at a pressure of 0.1 MPa for 8 minutes, after wet granulation with variable speed stirring, wet granulation is performed with a 4×4 mm sieve;
[0091] 2) Same as Example 1;
[0092] S2 is the same as Example 1.
[0093] The ascinimidazole hydrochloride tablets prepared in Examples 1-3 and Comparative Examples 1-6 were tested, and the test methods are shown in Table 4;
[0094] Table 4
[0095]
[0096]
[0097] The test results are shown in Table 5;
[0098] Table 5
[0099]
[0100]
[0101] As can be seen from Table 5, the asinethimide hydrochloride tablets prepared by the present invention have good dissolution, good uniformity of the central controlled dosage unit, good content uniformity and other indicators. The quality performance indicators of the asinethimide hydrochloride tablets can be effectively improved by optimizing the addition form of hydroxypropyl cellulose and by variable speed cutting and stirring wet granulation.
[0102] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.
[0103] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A kind of asciminid hydrochloride tablets, characterized in that: It is composed of aximini hydrochloride tablet core and a film coating, wherein the aximini hydrochloride tablet core comprises the following components in parts by weight: Assimil hydrochloride 20-45 parts, diluent A 40-90 parts, diluent B 20-60 parts, binder 2-10 parts, disintegrant 2-8 parts, glidant 0.2-1.2 parts, lubricant 0.5-2.5 parts.
2. The asciminid hydrochloride tablets according to claim 1, characterized in that: The diluent A is lactose monohydrate, the diluent B is microcrystalline cellulose, the binder is hydroxypropyl cellulose, the disintegrant is cross-linked sodium carboxymethyl cellulose, the glidant is colloidal silicon dioxide, and the lubricant is magnesium stearate.
3. The asciminid hydrochloride tablets according to claim 1, characterized in that: The asciminid hydrochloride tablet core comprises the following components in parts by weight: 21-22 parts of asciminid hydrochloride, 42-44 parts of diluent A, 28-29 parts of diluent B, 3.5-4.5 parts of binder, 2.5-3.5 parts of disintegrant, 0.3-0.7 parts of glidant, and 0.5-1.5 parts of lubricant.
4. The asciminid hydrochloride tablets according to claim 1, characterized in that: The asciminid hydrochloride tablet core comprises the following components in parts by weight: 43-44 parts of asciminid hydrochloride, 85-87 parts of diluent A, 57-58 parts of diluent B, 7.5-8.5 parts of binder, 5.5-6.5 parts of disintegrant, 0.5-1.5 parts of glidant and 1.5-2.5 parts of lubricant.
5. The asciminid hydrochloride tablets according to claim 1, characterized in that: The film coating comprises the following components in percentage: 70wt% of polyvinyl alcohol, 3wt% of titanium dioxide, 2wt% of talc, 10wt% of lecithin, 10wt% of xanthan gum, and 5wt% of colorant.
6. A method for preparing the ascinimidazole hydrochloride tablets according to any one of claims 1 to 5, characterized in that: The following steps are involved: S1. Preparation of Asinimipine Hydrochloride Tablet Cores: 1) Weighing the components of the tablet core according to their weight, and preparing an adhesive solution with a mass concentration of 8-12 wt % by using purified water; Adding diluent A, disintegrant, diluent B and binder solution to assimil hydrochloride to obtain a mixed material, wet granulating with variable speed cutting and stirring, and then wet granulating; 2) drying the prepared wet granules, adding a glidant, adding a lubricant after dry granulation, mixing, and tableting to obtain ascinimidazole hydrochloride tablet cores; S2. Preparation of Asinimid Hydrochloride Tablets: Weigh each component of the film coating according to the percentage content, then add each component of the film coating into water to prepare a solution with a mass concentration of 8-12wt%, and coat the core of the acinemide hydrochloride tablet to obtain the acinemide hydrochloride tablet.
7. The method for preparing ascinimid hydrochloride tablets according to claim 6, characterized in that: The variable speed cutting and stirring wet granulation comprises the following steps: A. High-speed stirring and low-speed cutting: The mixed materials are premixed at a stirring speed of 6-8rpm and a cutting rate of 0rpm for 4-6 minutes; B. High-speed cutting and low-speed stirring: adjust the stirring rate to 2-3rpm and the cutting rate to 20-30rpm for mixing, and atomize at a pressure of 0.05-0.2MPa for 6-10min.
8. The method for preparing ascinimid hydrochloride tablets according to claim 6, characterized in that: The specification of the wet granulation screen is 4×4 mm; the specification of the dry granulation screen is 1.2×1.2 mm.
9. The method for preparing ascinimid hydrochloride tablets according to claim 6, characterized in that: Fluidized bed drying is used to dry the mixture to a solid content of 1-3%.
Citation Information
Cited By
Preparation method of Aziminib hydrochloride tablet
CN121445697A
